SoylentNews is people
SoylentNews
The blowback against the U.S. Drug Enforcement Administration's decision to ban kratom has caught the attention of a bipartisan group of legislators, but a DEA spokesman has said that "It's not a matter of if. It's simply a matter of when" the DEA bans kratom:
A bipartisan group of nine senators is calling on the Drug Enforcement Administration to delay its "unprecedented" decision to ban kratom, a plant that researchers say holds great potential for mitigating the effects of the opioid epidemic. [...] The Senate letter, spearheaded by Orrin G. Hatch (R-Utah) says: "Congress granted emergency scheduling authority to the DEA based on the need for law enforcement interdiction of new and previously unknown illegal synthetic street drugs that result in injuries and death. The use of this emergency authority for a natural substance is unprecedented, so it is important to determine whether the circumstances here necessitate a jump to Schedule I.
"Given the long reported history of Kratom use," the letter continues, "coupled with the public's sentiment that it is a safe alternative to prescription opioids, we believe using the regular review process would provide for a much-needed discussion among all stakeholders." [...] The DEA cites 600-plus poison-control center calls involving kratom between 2010 and 2015 in its justification for banning the plant, and notes that 15 deaths were linked to the use of the plant between 2014 and 2016. In an interview with The Washington Post, a DEA spokesman later clarified that all but one of those fatalities involved the use of other substances. Earlier this week 51 U.S. representatives similarly called on the DEA and the White House to reconsider or at least delay the ban, which was slated to go into effect as early as Friday. In an interview, DEA spokesman Russell Baer confirmed that the ban was not yet in place. "We have not yet determined a date when we will publish that final order" putting the ban into effect, he said.
There may be a public comment period before the ban takes effect, and the White House is now obligated to respond to the petition about kratom, which has reached over 140,000 signatures.
Text of the Senators' letter. Also at Ars Technica, CBS, and US News & World Report.
Previously: DEA Welcomes Kratom to the Schedule I List Beginning September 30
Heroin, Fentanyl? Meh: Carfentanil is the Latest Killer Opioid
Alcohol Industry Bankrolls Fight Against Legal Pot in Battle of the Buzz [Updated]
(Score: 5, Insightful) by edIII on Saturday October 01 2016, @08:03PM
What? The harm is out there for everyone to see man! Will nobody think of the lost profits for the pharmaceutical industries?!
We just can't have some natural plant take over opiate markets like an invasive species. Perhaps, when Kratom is studied more and can be monetized we will re-discover its medical properties. On another note, if we deregulate all the drugs how will the DEA continue to survive and provide jobs? How will local law enforcement be able to mass seize property to raise funds to continue to fight the scourge that is self-help medical?
Technically, lunchtime is at any moment. It's just a wave function.
(Score: 0, Disagree) by Anonymous Coward on Saturday October 01 2016, @10:28PM
This has nothing to do with the "lost profits of the pharmaceutical industries" and everything to do with the "lost profits of the dietary supplement industry".
(Score: 3, Informative) by tathra on Sunday October 02 2016, @01:02AM
schedule 1 bans all research, so this move is preventing pharmaceutical companies from monetizing it as well.
(Score: 4, Informative) by takyon on Sunday October 02 2016, @01:15AM
Not entirely true, but it does make it harder [soylentnews.org]:
The DEA approves the cannabis studies and controls the supply, so you could easily see how they could pick and choose researchers more likely to conform to their backwards views or do scarier studies starting from a point of studying cannabis "abuse".
[SIG] 10/28/2017: Soylent Upgrade v14 [soylentnews.org]